Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Bio-Techne Corporation Revenue & Financial Statements
Bio-Techne Corporation reported revenue of $1.2B for the fiscal year ended June 30, 2025, up 5.2% year over year, with net income of $73.4M and diluted EPS of $0.46.
- Company
- Bio-Techne Corporation TECH · NASDAQ
- Latest fiscal year
- FY ended Jun 30, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 931.0M | 1.1B | 1.1B | 1.2B | 1.2B |
| Cost of revenue | 298.2M | 349.1M | 366.9M | 389.3M | 429.4M |
| Gross profit | 632.9M | 756.5M | 769.8M | 769.7M | 790.3M |
| Operating income | 237.3M | 296.6M | 298.9M | 206.7M | 102.3M |
| Pretax income | 95.7M | 255.1M | 288.5M | 174.8M | 86.8M |
| Net income | 140.3M | 271.9M | 285.2M | 168.1M | 73.4M |
| Diluted EPS | 3.47 | 6.63 | 1.76 | 1.05 | 0.46 |
| EBITDA | 325.0M | 397.7M | 406.2M | 318.4M | 136.9M |
Quarterly
| USD | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 303.4M | 306.1M | 289.5M | 297.0M | 316.2M | 317.0M | 286.6M | 295.9M |
| Cost of revenue | 98.8M | 102.8M | 106.4M | 103.1M | 101.6M | 118.2M | 98.4M | 104.6M |
| Gross profit | 204.6M | 203.3M | 183.0M | 193.9M | 214.6M | 198.8M | 188.1M | 191.3M |
| Operating income | 67.0M | 45.8M | 40.0M | 47.4M | 38.7M | (23.9M) | 47.7M | 54.5M |
| Pretax income | 61.1M | 41.7M | 40.2M | 42.9M | 38.3M | (22.9M) | 48.0M | 50.8M |
| Net income | 49.1M | 40.6M | 33.6M | 34.9M | 22.6M | (17.7M) | 38.2M | 38.0M |
| Diluted EPS | 0.31 | 0.26 | 0.21 | 0.22 | 0.14 | -0.11 | 0.24 | 0.24 |
| EBITDA | 94.3M | 73.9M | 68.1M | — | 66.3M | 3.3M | 72.0M | — |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 2.3B | 2.3B | 2.6B | 2.7B | 2.6B |
| Current assets | 510.6M | 605.6M | 621.5M | 617.4M | 608.3M |
| Cash & equivalents | 199.1M | 172.6M | 180.6M | 151.8M | 162.2M |
| Total liabilities | — | — | — | — | — |
| Current liabilities | 152.3M | 176.0M | 128.5M | 159.4M | 175.8M |
| Long-term debt | — | — | — | — | — |
| Total debt | 12.5M | 12.5M | — | — | — |
| Stockholders’ equity | 1.6B | 1.7B | 2.0B | 2.1B | — |
| Net debt | (186.6M) | (160.1M) | — | — | — |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 352.2M | 325.3M | 254.4M | 299.0M | 287.6M |
| Investing cash flow | (243.5M) | (96.9M) | (265.6M) | (203.0M) | (35.2M) |
| Financing cash flow | (62.6M) | (242.9M) | 22.6M | (122.4M) | (253.9M) |
| Capital expenditure | 44.3M | 44.9M | 38.2M | 62.9M | 31.0M |
| Free cash flow | 307.9M | 280.4M | 216.1M | 236.1M | 256.6M |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 49.0M | 42.2M | 39.2M | 38.0M | 40.8M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every TECH filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.